stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. ANGO
    stockgist
    HomeTop MoversCompaniesConcepts
    ANGO logo

    AngioDynamics, Inc.

    ANGO
    NASDAQ
    Healthcare
    Medical - Instruments & Supplies
    Latham, NY, US748 employeesangiodynamics.com
    $10.31
    -1.63(-13.61%)

    Mkt Cap $425M

    $8.40
    $13.64

    52-Week Range

    At a Glance

    AI-generated

    Revenue breakdown: Med Device Segment (64.7%), Med Tech Segment (35.3%).

    8-K
    AngioDynamics reported fiscal Q3 2026 net sales of $78.4 million (+8.9% YoY) and raised its full-year FY2026 guidance for net sales and Adjusted EBITDA, driven by 19.0% growth in its Med Tech segment.

    $425M

    Market Cap

    $306M

    Revenue

    -$28M

    Net Income

    Employees748
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Med Device Segment64.7%($1.2B)
    Med Tech Segment35.3%($659M)

    Revenue by Geography

    US77.7%($1.6B)
    Non Us14.8%($300M)
    International7.4%($150M)
    Activity

    What Changed Recently

    Management Change
    Feb 2, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Transition an

    Financial Results
    Apr 1, 2026

    of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

    Financial Results
    Jan 5, 2026

    of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

    Regulation FD
    Jan 13, 2026

    of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    RAPTRAPT Therapeutics, Inc.$58.01+0.00%$959M-14.8
    CGEMCullinan Therapeutics, In...$14.45+3.66%$875M-3.5
    OMEROmeros Corporation$10.94-9.44%$776M-5.8
    OCGNOcugen, Inc.$1.78-0.28%$585M-9.7
    SNDASonida Senior Living, Inc...$32.10+0.00%$581M-8.1
    VREXVarex Imaging Corporation$10.51-1.04%$441M-6.7
    FULCFulcrum Therapeutics, Inc...$8.06+7.75%$436M-5.8
    SYSo-Young International In...$2.85+3.82%$376M-3.5
    Analyst View
    Company Profile
    CIK0001275187
    ISINUS03475V1017
    CUSIP03475V101
    Phone518 795 1400
    Address14 Plaza Drive, Latham, NY, 12110, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice